NCT00353912

Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension

A 12-week, Multicenter Study to Evaluate the Efficacy and Safety of Orally Administered Valsartan/Amlodipine Combo Based Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 571 (actual)
• Sponsor: Novartis · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: —

Summary

The purpose of this study is to evaluate the blood pressure lowering effects of a valsartan/amlodipine combination treatment and amlodipine monotherapy for the treatment of Black stage II hypertensive patients (MSSBP ≥ 160 mmHg).

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	valsartan + amlodipine

Timeline

• Start date: 2006-06-01
• Primary completion: 2007-04-01
• Completion: 2007-04-01
• First posted: 2006-07-19
• Last updated: 2016-11-18

Locations

1 site across 1 country: United States